Teva May Increase Mylan Proposal to $43B This Week

Jul 08, 2015


Bloomberg reported that Teva Pharmaceutical Industries Ltd. will likely increase its bid for rival Mylan NV by as much as $2 billion, to $43 billion, and may announce the new proposal as soon as this week.

Teva may offer $86 to $88 a share for Mylan, said unnamed sources. That compares with the $82 a share Teva offered in April, a price that valued the Canonsburg, Pennsylvania-based company at about $40.1 billion, the article said. Mylan had a market value of about $34.4 billion as of last week’s close.

Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments